Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2013 Results
Date:7/31/2013

WASHINGTON, July 31, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and operational results for the second quarter ended June 30, 2013.

Key Highlights:

  • On July 29, 2013 Vanda announced that the U.S. Food and Drug Administration (FDA) accepted the filing and granted priority review classification to Vanda's New Drug Application (NDA) for tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24) in the totally blind.
  • The FDA determined the action target date under Prescription Drug User Fee Act (PDUFA-V) to be January 31, 2014.  The FDA has also tentatively scheduled an advisory committee meeting to discuss the tasimelteon application on November 14, 2013.
  • Full year 2013 decrease in cash, cash equivalents and marketable securities (Cash) is expected to be between $45.0 and $50.0 million, consistent with prior guidance.
  • Vanda recorded second quarter 2013 revenue of $8.3 million including royalties of $1.6 million.  Fanapt® prescriptions, as reported by IMS, were approximately 41,400 for the second quarter of 2013.  This represents a 11% increase over second quarter 2012 prescriptions and a 7% increase over first quarter 2013 prescriptions.
  • SECOND QUARTER 2013 REPORTED RESULTSTotal revenues for the second quarter of 2013 were $8.3 million, compared to $8.4 million for the same period in 2012.  Second quarter 2013 revenues included $1.6 million in Fanapt® royalties received from Novartis as compared to royalties of $1.7 million for the second quarter of 2012.

    Total operating expenses for the second quarter of 2013 were $1
    '/>"/>

    SOURCE Vanda Pharmaceuticals Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
    2. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
    3. Vanda Pharmaceuticals, Inc. Sued by Investor
    4. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
    5. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
    6. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
    7. Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
    8. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
    9. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
    10. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
    11. Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... SOUTH EASTON, Mass. , Sept. 19, 2014 ... the "Company") today announced it has received and ... throughput Barozyme HT48 instruments and has begun to ... believes the first instrument will be ready for ... will be built and released at a rate ...
    (Date:9/19/2014)... , Sept. 19, 2014  The body of ... the publication of two papers this past week.  The ... Head and Neck Surgery , finds that withholding ... subjective measures of sleep disordered breathing, leading the paper,s ... in obstructive sleep apnea severity and improvement of quality ...
    (Date:9/19/2014)... VIENNA , Sept. 19, 2014 ... positive interim clinical data for its lead candidate ITCA ... diabetes patients with high baseline HbA1c levels at the ... for the Study of Diabetes (EASD). Data from the ... reduced levels of blood sugar in patients with poorly ...
    Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
    ... 2012  Legal-Bay, announced today that their applications for Transvaginal ... sharply since the company began funding plaintiffs for Mesh ... the legal funding industry do not fund Vaginal Mesh ... industry leader who is one of the few companies ...
    ... NORTHRIDGE, Calif., April 2, 2012 No matter the advances ... Americans are suffering with tooth damage and decay every single ... 25 percent of all adults as well as 16 percent ... restore the integrity and appearance of smiles, the most trusted ...
    Cached Medicine Technology:Vaginal Mesh and Kugel Hernia Mesh Case Applications for Lawsuit Funding on the Rise at Legal-Bay Settlement Funding 2Northridge Cosmetic Dentists, Dr. Michel Elyson and Dr. Ramin Assili, are Now Offering Advanced Tooth Colored Restorations to Restore Smiles 2
    (Date:9/21/2014)... 2014 (HealthDay News) -- Young women starting college understand ... foods they should eat. But they aren,t confident they ... to a new study. The study involved ... Illinois,s Peer Education Exercising and Eating Right program. The ... choose to eat if they were very busy with ...
    (Date:9/21/2014)... September 21, 2014 Discount-Dress.com, ... accessories, has recently announced its decision to implement a ... shopping easier for ladies across the world. Furthermore, the ... dresses for ladies. , The new items come ... with discounted prices, up to 56 percent off. "We ...
    (Date:9/21/2014)... 21, 2014 Market Research ... 49562-28-9) Industry, 2009-2019 is a professional and ... Fenofibrate (CAS 49562-28-9) industry. The report firstly ... 49562-28-9) including its classification, application and manufacturing ... top manufacturers of Fenofibrate (CAS 49562-28-9) listing ...
    (Date:9/21/2014)... High in the rugged Gore Range ... able-bodied athletes rafted the Colorado River, rode mountain bikes ... pursuit of outdoor adventure. At the September 12-14 ... Sports, disabilities proved to be no more than an ... stage event. , Each participating team of five athletes ...
    (Date:9/21/2014)... An experienced review website in the global market, Top10BestSEOHosting.com, ... announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and Bluehost ... has been a boom in websites in recent years, ... in the number of web hosting companies that offer ... VPS (Virtual Private Server) is the method of partitioning ...
    Breaking Medicine News(10 mins):Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Discount-Dress.com Implements A New Shopping Cart Software And Provides New Beach Wedding Dresses 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2
    ... Thompson HealthDay Reporter , FRIDAY, Dec. 17 (HealthDay ... gadgets and gizmos. But as toys become more sophisticated, they ... parents and gift-givers to consider. Tiny magnets, powerful batteries ... that can be just as dangerous as small parts and ...
    ... ISRAEL, December 17, 2010 As middle ear infections ... of the Negev (BGU) suggest that in many cases ... of using antibiotics immediately. The review, published in ... , does not suggest use of watchful waiting in ...
    ... published today by SAGE, is the first comprehensive textbook ... all of their undergraduate studies. Following the General Medical ... degree courses, this groundbreaking textbook does just that - ... to know. Psychology for medicine aims to give a ...
    ... FRIDAY, Dec. 17 (HealthDay News) -- Differences in immune ... are more susceptible than other primates to certain infectious ... to the progression of HIV to AIDS or severe ... humans are more sensitive than chimpanzees to the serious ...
    ... Children and adults with kidney disease caused by the autoimmune ... with other types of kidney disease, researchers have found. ... more parts of the body, such as the eyes, joints, ... with lupus suffer kidney damage. In the new study, ...
    ... , FRIDAY, Dec. 17 (HealthDay News) Christmas and other ... year, which makes it all the more stressful when they ... the year when people are especially vulnerable to depression, Dr. ... said in a university news release. Shopping and entertaining can ...
    Cached Medicine News:Health News:Not Just the Newest Toys Hold Risks for Kids 2Health News:Not Just the Newest Toys Hold Risks for Kids 3Health News:Not Just the Newest Toys Hold Risks for Kids 4Health News:Ben-Gurion U. researchers: High resistance rates among acute otitis media pathogens in children 2Health News:Psychology for medicine -- a brand new outlook 2Health News:Primate Immune System Differences Identified 2Health News:Kidney Disease Could Be More Deadly for Kids With Lupus 2Health News:Surviving the Holiday Blues 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: